Hoth Financial Statements From 2010 to 2026

HOTH Stock  USD 1.09  0.05  4.81%   
Hoth Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Hoth Therapeutics' valuation are provided below:
Market Capitalization
16.8 M
Earnings Share
(1.02)
We have found one hundred twenty available fundamental trends for Hoth Therapeutics, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Hoth Therapeutics regular fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 5.2 M. The Hoth Therapeutics' current Enterprise Value is estimated to increase to about (2.4 M)
Check Hoth Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hoth Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 668, Depreciation And Amortization of 9.9 M or Interest Expense of 368.8 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.76. Hoth financial statements analysis is a perfect complement when working with Hoth Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Hoth Stock
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

Hoth Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.3 M8.9 M4.1 M
Slightly volatile
Other Current Liabilities361.9 K449.4 K203.2 K
Slightly volatile
Total Current Liabilities676 K955.9 K405.5 K
Slightly volatile
Total Stockholder Equity5.5 M7.9 M3.6 M
Slightly volatile
Net Tangible Assets11.9 M11.4 M4.7 M
Slightly volatile
Accounts Payable306.2 K473.9 K196.6 K
Slightly volatile
Cash5.1 M8.1 M3.5 M
Slightly volatile
Non Current Assets Total74.2 K78.1 K85.1 K
Slightly volatile
Cash And Short Term Investments5.8 M8.1 M3.8 M
Slightly volatile
Common Stock Total Equity9161.5 K850
Slightly volatile
Common Stock Shares Outstanding7.7 M7.3 M1.8 M
Slightly volatile
Liabilities And Stockholders Equity6.3 M8.9 M4.1 M
Slightly volatile
Non Current Liabilities Total2.3 K2.4 K102 K
Pretty Stable
Capital Surpluse29.1 M27.7 M13.1 M
Slightly volatile
Other Stockholder Equity81.2 M77.4 M26.5 M
Slightly volatile
Total Liabilities785.8 K959 K459.2 K
Slightly volatile
Net Invested Capital5.4 M7.9 M3.6 M
Slightly volatile
Total Current Assets6.1 M8.8 MM
Slightly volatile
Net Working Capital5.3 M7.8 M3.5 M
Slightly volatile
Common Stock976925723
Slightly volatile
Property Plant Equipment1.8 K9392.3 K
Slightly volatile
Other Current Assets322 K643.1 K280.4 K
Slightly volatile
Preferred Stock Total Equity248279305
Slightly volatile
Capital Stock793724882
Very volatile
Other Liabilities208 K211.5 K264.4 K
Slightly volatile
Long Term Investments31.5 K33.1 K299.5 K
Slightly volatile
Non Current Liabilities Other228 K256.5 K280 K
Slightly volatile
Net Receivables38.3 K42.1 K48.3 K
Slightly volatile
Short and Long Term Debt Total34.5 K28 K50.9 K
Slightly volatile
Short Term Debt22.9 K25.5 K28.3 K
Slightly volatile

Hoth Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative4.3 M5.7 M2.6 M
Slightly volatile
Selling And Marketing Expenses2.4 M4.8 M2.1 M
Slightly volatile
Other Operating Expenses8.3 M9.4 M5.4 M
Slightly volatile
Research Development3.5 M3.7 M2.2 M
Slightly volatile
Cost Of Revenue73 K76.9 K2.8 M
Pretty Stable
Total Operating Expenses8.3 M9.4 M5.4 M
Slightly volatile
Reconciled Depreciation106112823
Slightly volatile
Non Operating Income Net Other63 K119.8 K47.5 K
Slightly volatile

Hoth Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation781.2 K723.8 K1.2 M
Slightly volatile
Other Cashflows From Financing Activities4.4 M4.2 M827 K
Slightly volatile
Depreciation106112336
Very volatile
Total Cash From Financing Activities8.2 M5.5 M5.1 M
Slightly volatile
End Period Cash Flow5.1 M8.1 M3.5 M
Slightly volatile
Change To Netincome1.2 M1.5 M1.8 M
Slightly volatile
Begin Period Cash Flow11.2 M10.7 M3.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio0.760.865.2149
Pretty Stable
Book Value Per Share1.181.243.6713
Very volatile
Average Payables261.7 K201.4 K282.4 K
Very volatile
Capex To Depreciation175185838
Slightly volatile
PB Ratio0.760.865.2149
Pretty Stable
Payables Turnover0.08220.08657.695
Pretty Stable
Cash Per Share1.211.273.8928
Very volatile
Days Payables Outstanding4.1 K4.4 K45.4 K
Slightly volatile
Income Quality0.620.770.5391
Slightly volatile
Net Debt To EBITDA0.730.777.5981
Slightly volatile
Current Ratio12.0710.5816.7362
Slightly volatile
Tangible Book Value Per Share1.181.243.6713
Very volatile
Shareholders Equity Per Share1.181.243.6713
Very volatile
Debt To Equity0.00590.00520.0061
Slightly volatile
Capex Per Share0.00.00.4334
Slightly volatile
Average Receivables18.7 K21 K23 K
Slightly volatile
Interest Debt Per Share0.00530.00560.1969
Slightly volatile
Debt To Assets0.00540.00460.0056
Slightly volatile
Price Book Value Ratio0.760.865.2149
Pretty Stable
Days Of Payables Outstanding4.1 K4.4 K45.4 K
Slightly volatile
Ebt Per Ebit1.121.151.0546
Pretty Stable
Company Equity Multiplier1.541.291.2565
Pretty Stable
Total Debt To Capitalization0.00590.00520.006
Slightly volatile
Debt Equity Ratio0.00590.00520.0061
Slightly volatile
Quick Ratio12.0710.5816.7362
Slightly volatile
Net Income Per E B T0.80.90.9812
Slightly volatile
Cash Ratio10.259.7415.8055
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.251.161.3371
Slightly volatile
Price To Book Ratio0.760.865.2149
Pretty Stable
Debt Ratio0.00540.00460.0056
Slightly volatile
Price Fair Value0.760.865.2149
Pretty Stable

Hoth Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.2 M5.5 M51 M
Slightly volatile

Hoth Fundamental Market Drivers

Hoth Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Hoth Therapeutics Financial Statements

Investors use fundamental indicators, such as Hoth Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Hoth Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cost Of Revenue76.9 K73 K

Currently Active Assets on Macroaxis

When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.02)
Return On Assets
(0.84)
Return On Equity
(1.51)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.